Amphastar Pharmaceuticals (Amphastar Pharmaceuticals) Price-to-Operating-Cash-Flow

: 11.58 (As of Today)

View and export this data going back to 2014. Start your Free Trial

As of today (2024-04-19), Amphastar Pharmaceuticals's share price is $40.01. Amphastar Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $3.45. Hence, Amphastar Pharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is 11.58.

The historical rank and industry rank for Amphastar Pharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:

AMPH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.95 Med: 20.76 Max: 60.04
Current: 11.53

During the past 13 years, Amphastar Pharmaceuticals's highest Price-to-Operating-Cash-Flow Ratio was 60.04. The lowest was 2.95. And the median was 20.76.

AMPH's Price-to-Operating-Cash-Flow is ranked better than
66.27% of 676 companies
in the Drug Manufacturers industry
Industry Median: 17.36 vs AMPH: 11.53

Amphastar Pharmaceuticals's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $0.45. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $3.45.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Amphastar Pharmaceuticals was 103.50% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 43.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 32.40% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 10.90% per year.

During the past 13 years, Amphastar Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 51.20% per year. The lowest was -40.60% per year. And the median was 17.30% per year.

Amphastar Pharmaceuticals Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Amphastar Pharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Array ( [0] => - [1] => - [2] => - [3] => - [4] => - [5] => 23.05 [6] => 17.25 [7] => 11.83 [8] => 16.47 [9] => 17.87 )

Amphastar Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

23.05

17.25

11.83

16.47

17.87

Amphastar Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow																16.47	24.83	23.07	13.94	17.87

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Amphastar Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amphastar Pharmaceuticals Price-to-Operating-Cash-Flow Distribution

For the Drug Manufacturers industry and Healthcare sector, Amphastar Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Amphastar Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Amphastar Pharmaceuticals Price-to-Operating-Cash-Flow Calculation

Amphastar Pharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	40.01	/	3.454
	=	11.58

Amphastar Pharmaceuticals's Share Price of today is $40.01.
Amphastar Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.45.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Amphastar Pharmaceuticals Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Amphastar Pharmaceuticals's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Amphastar Pharmaceuticals (Amphastar Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amphastar Pharmaceuticals Inc (NAS:AMPH) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

29A:Germany 29A:Germany

Address

11570 6th Street, Rancho Cucamonga, CA, USA, 91730

Website

http://www.amphastar.com

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Executives

Mary Z. Luo	director, 10 percent owner, officer: COO and Chief Scientist	11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Floyd F. Petersen	director	11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Rong Zhou	officer: EVP, Production	C/O AMPHASTAR PHARMACEUTICALS INC., 11570 SIXTH STREET, RANCHO CUCAMONGA CA 91730
Richard K Prins	director
William J Peters	officer: CFO, SVP & Treasurer	C/O AMPHASTAR PHARMACEUTICALS, INC., 11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Yakob Liawatidewi	officer: SVP Corp Admin Center	C/O AMPHASTAR PHARMACEUTICALS INC, 11570 SIXTH STREET, RANCHO CUCAMONGA CA 91730
Michael A Zasloff	director
Gayle Deflin	director	11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Diane G. Gerst	officer: EVP, QA & Regulatory Affairs	11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Howard Lee	director	13F-2, NO. 36, LANE 48, SECTION 3, NAN-JING EAST ROAD, TAIPEI, TAIWAN F4 00000
Jack Y. Zhang	director, 10 percent owner, officer: CEO & Chief Scientific Officer	11570 6TH STREET, RANCHO CUCAMONGA CA 91730
David Maris	director	C/O AMPHASTAR PHARMACEUTICALS, INC., 11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Richard Koo	director	11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Jason B. Shandell	director, officer: President	11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Applied Physics & Chemistry Laboratories, Inc.	10 percent owner	13760 MAGNOLIA AVENUE, CHINO CA 91710